3D printing has rapidly emerged as a transformative force in medicine, bringing customized, precise, and affordable solutions to a wide array of clinical applications. As technology evolves, future breakthroughs will increasingly transition from conventional applications to highly sophisticated developments such as bioprinting of vascularized tissue and organs, nanoscale resolution printing, and point-of-care manufacturing (PoCM) driven by artificial intelligence and real-time patient information. Bioprinting can revolutionize regenerative medicine by creating functional tissues for transplantation and disease modeling, while nanotechnology integration promises enhanced mechanical properties, drug targeting delivery systems, and smart implants. On the other hand, PoCM platforms bring a paradigm shift toward decentralized, on-demand healthcare delivery with high impact in emergency, remote, and resource-poor settings. However, despite these promising prospects, the technology faces significant technical, regulatory, and economic challenges. Key challenges include the limited availability of biocompatible and functional materials, the scalability of complex constructs, regulatory normalization, and the affordability of advanced manufacturing technologies. Such challenges will be surmounted by interdisciplinary collaboration, rigorous quality control regimes, and the development of new economic and ethical norms. This chapter outlines the trajectory of 3D printing in medicine, with future directions and the multifaceted challenges that must be overcome to reach its full clinical potential.